Arkolith/Insider Trading/RPTX/Form 4

Forte Steve

EVP, CHIEF FINANCIAL OFFICERRepare Therapeutics Inc. (RPTX) · full profile →Form 4 · filed Jan 28, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 28, 2026Disposed to issuer(D)57K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 28, 2026Disposed to issuer(D)326K—$00
Jan 28, 2026Disposed to issuer(D)500K—$00
Jan 28, 2026Disposed to issuer(D)85K—$00
Jan 28, 2026Disposed to issuer(D)200K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001815428-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML